BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Battistelli S, Stefanoni M, Genovese A, Vittoria A, Cappelli R, Roviello F. Prevalence of factor V Leiden and prothrombin G20210A in patients with gastric cancer. World J Gastroenterol 2006; 12(26): 4179-4180 [PMID: 16830369 DOI: 10.3748/wjg.v12.i26.4179]
URL: https://www.wjgnet.com/1007-9327/full/v12/i26/4179.htm
Number Citing Articles
1
Aydan Eroğlu, Afife Karabıyık, Nejat Akar. The Association of Protease Activated Receptor 1 gene −506 I/D Polymorphism with Disease-Free Survival in Breast Cancer PatientsAnnals of Surgical Oncology 2012; 19(4): 1365 doi: 10.1245/s10434-011-1969-8
2
Anita Zia, Mahmood Shams, Ali Dabbagh, Milad Shahsavari, Akbar Dorgalaleh. Cancer-associated thrombosis: the role of inherited thrombophiliaBlood Coagulation & Fibrinolysis 2024; 35(6): 297 doi: 10.1097/MBC.0000000000001317
3
Hervé Decousus, Nathalie Moulin, Sara Quenet, Vincent Bost, Karine Rivron-Guillot, Silvy Laporte, Patrick Mismetti. Thrombophilia and risk of venous thrombosis in patients with cancerThrombosis Research 2007; 120: S51 doi: 10.1016/S0049-3848(07)70130-5
4
Daniela Tormene, Paola Beltramello, Marica Perlati, Barbara Brandolin, Sofia Barbar, Giuseppe De Toffoli, Paolo Simioni. The Risk of Cancer Progression in Women With Gynecological Malignancies and Thrombophilic Polymorphisms: A Pilot Case-Control StudyClinical and Applied Thrombosis/Hemostasis 2009; 15(5): 535 doi: 10.1177/1076029608317941
5
Mari Tinholt, Per Morten Sandset, Nina Iversen. Polymorphisms of the coagulation system and risk of cancerThrombosis Research 2016; 140: S49 doi: 10.1016/S0049-3848(16)30098-6
6
Mari Tinholt, Marte Kathrine Viken, Anders Erik Dahm, Hans Kristian Moen Vollan, Kristine Kleivi Sahlberg, Øystein Garred, Anne-Lise Børresen-Dale, Anne Flem Jacobsen, Vessela Kristensen, Ida Bukholm, Rolf Kåresen, Ellen Schlichting, Grethe Skretting, Benedicte Alexandra Lie, Per Morten Sandset, Nina Iversen. Increased coagulation activity and genetic polymorphisms in the F5, F10 and EPCRgenes are associated with breast cancer: a case-control studyBMC Cancer 2014; 14(1) doi: 10.1186/1471-2407-14-845
7
Valéria Tavares, Beatriz Vieira Neto, Maria Isabel Vilas-Boas, Deolinda Pereira, Rui Medeiros. Impact of hereditary thrombophilia on cancer-associated thrombosis, tumour susceptibility and progression: A review of existing evidenceBiochimica et Biophysica Acta (BBA) - Reviews on Cancer 2022; 1877(5): 188778 doi: 10.1016/j.bbcan.2022.188778
8
Yi Liu, Xi-Wen Liao, Yu-Zhou Qin, Xian-Wei Mo, Shan-Shan Luo. Identification of F5 as a Prognostic Biomarker in Patients with Gastric CancerBioMed Research International 2020; 2020: 1 doi: 10.1155/2020/9280841
9
Elie G. Aoun, Khaled M. Musallam, Mohamad Abou-Ghazal, Ali T. Taher. Malignancy and hypercoagulability: a two-way association revisitedJournal of Thrombosis and Thrombolysis 2010; 30(3): 340 doi: 10.1007/s11239-010-0458-4
10
Aydan Eroglu, Ragip Çam, Yonca Eğin, Nejat Akar. Factor V Leiden and prothrombin G20210A polymorphisms are not associated with disease-free survival in breast cancerBreast Cancer Research and Treatment 2009; 116(3): 619 doi: 10.1007/s10549-008-0177-0
11
Mona Ahmed Wahba, Mona Ahmed Ismail, Abeer Attia Saad, Deena Mohamed Habashy, Zeinab Mohamed Abdel Hafeez, Noha Hussein Boshnak. Impact of thrombophilic genes mutations on thrombosis risk in Egyptian nonmetastatic cancer patientsBlood Coagulation & Fibrinolysis 2015; 26(3): 309 doi: 10.1097/MBC.0000000000000242